You are here

Article info

Article menu
Download PDFPDF
PostScript
Letter
Minimal supportive treatment in natalizumab-related PML in a MS patient

Authors

  • Patrice H Lalive Unit of Neuroimmunology and Multiple Sclerosis, Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospital and Faculty of Medicine of the University of Geneva, Geneva, Switzerland Division of Laboratory Medicine, Department of Genetic and Laboratory Medicine, Geneva University Hospital, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Claire Bridel Unit of Neuroimmunology and Multiple Sclerosis, Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospital and Faculty of Medicine of the University of Geneva, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Ruxandra Iancu Ferfoglia Unit of Neuroimmunology and Multiple Sclerosis, Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospital and Faculty of Medicine of the University of Geneva, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Laurent Kaiser Division of Laboratory Medicine, Department of Genetic and Laboratory Medicine, Geneva University Hospital, Geneva, Switzerland Laboratory of Virology, Division of Infectious Diseases, University of Geneva Hospitals and University of Geneva Medical School, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Renaud Du Pasquier Division of Neurology, Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland Division of Immunology and Allergy, Department of Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • Frederik Barkhof Department of Radiology & Nuclear Medicine and Image Analysis Centre (IAC), VU University Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Sven Haller Department of Imaging and Medical Informatics, University Hospitals of Geneva and Faculty of Medicine of the University of Geneva, Geneva, Switzerland PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sven Haller, Service neuro-diagnostique et neuro-interventionnel DISIM, University Hospitals of Geneva, rue Gabrielle Perret-Gentil 4, 1211 Geneva 14, Switzerland; sven.haller{at}hcuge.ch
View Full Text

Citation

Lalive PH, Bridel C, Ferfoglia RI, et al
Minimal supportive treatment in natalizumab-related PML in a MS patient
Journal of Neurology, Neurosurgery & Psychiatry 2015;86:354-355.

Publication history

  • Received March 21, 2014
  • Accepted May 26, 2014
  • First published June 23, 2014.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions